AnsariSH,ShamsiTS,AshrafM,FarzanaT,BohrayM,PerveenK,,2012,Molecular epidemiology of β-thalassemia in Pakistan: Far reaching implications,Indian J Hum Genet,18,193-7
AngelaV,GiuseppinaC,ElianaL,GraziaC,AlessandraQ,CalogeraG,,2017,The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the majorintermedia dichotomy?,Br J Haematol,176,124-30
AnsariSH,ShamsiTS,SiddiquiFJ,IrfanM,PerveenK,FarzanaT,,2007,Efficacy of hydroxyurea (HU) in reduction of pack red cell (PRC) transfusion requirement among children having betathalassemia major: Karachi HU trial (KHUT),J Pediatr Hematol Oncol,29,743-6
Ahmed KianiR,AnwarM,WaheedU,AsadMJ,AbbasiS,,2016,Epidemiology of Transfusion Transmitted Infection among Patients with β-Thalassaemia Major in Pakistan,J Blood Transfus,,5-
ZaheerHA,WaheedU,,2014,Blood safety system reforms in Pakistan,J Blood Transfus,12,452-7
ShamsiT,AnsariS.,,2013,Medical management of beta-thalassaemia without blood transfusion: a myth or a reality?,J Pak Med Assoc,63,304-5
EjazMS,BalochS,,2015,Efficacy and adverse effects of oral chelating therapy (deferasirox) in multi-transfused Pakistani children with β-thalassemia major,Pak J Med Sci,31,621-5
RiazH,RiazT,KhanMU,AzizS,UllahF,RehmanA,,2011,Serum ferritin levels, socio-demographic factors and desferrioxamine therapy in multi-transfused thalassemia major patients at a government tertiary care hospital of Karachi, Pakistan,BMC Res Notes,4,287-
AliN,AdilSN,ShaikhMU,MasoodN.,Frequency,,2013,6 pages),ISRN Hematol,232519,-
AljurfM,ZaidiSZ,El SolhH,HussainF,GhavamzadehA,MahmoudHK,,2009,Special Issues Related to Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region and the First Regional Activity Report,Bone Marrow Transplant,43,1-12
DhirarN,KhandekarJ,BachaniD,Mahto D. Thalassemia,,1895,Major: how do we improve quality of life?,Springer Plus,5,-
ElalfyMS,FaridMN,LabibJH,RezkAllahHK,,2014,Quality of life of Egyptian b-thalassemia major children and adolescents,Egypt J Haematol,39,222-
Jafari-ShakibA,Davoudi-KiakalayeA,Pour-FathollahA,JafariShakibR,Mohtasham-Amiri Z. Health-Related Quality,,2016,,Iran J Blood Canc,8,108-11
KlaassenR,AlibhaiS,Kirby AllenM,MoreauK,MerellesPulciniM,ForgieM,,2013,Introducing the TranQol: a new disease-specific quality of life measure for children and adults with thalassemia major,J Blood Disord Transfus,,4-
KlaassenRJ,BarrowmanN,Merelles‐PulciniM,VichinskyEP,SweetersN,Kirby‐AllenM,,2014,Validation and reliability of a disease‐specific quality of life measure (the TranQol) in adults and children with thalassaemia major,Br J Haematol,164,431-7
Abdul NasirJ,ZaidiSA,,2009,Modelling survival data of thalassaemia patients in Pakistan,Journal of Ayub Medical College, Abbottabad: J Ayub Med Coll Abbottabad,21,142-5
RiazH,RiazT,KhanMU,AzizS,UllahF,RehmanA,,2011,Serum ferritin levels, socio-demographic factors and desferrioxamine therapy in multi-transfused thalassemia major patients at a government tertiary care hospital of Karachi, Pakistan,BMC Res Notes,4,287-
AnsariS,BaghersalimiA,AzarkeivanA,NojomiM,RadAH,,2014,Quality of life in patients with thalassemia major,Iran J Ped Hematol Oncol,4,57-
TurnerJ,KellyB,,2000,Emotional dimensions of chronic disease,West J Med,172,124-8
,2001,Improving Chronic Illness Care: Translating Evidence into Action,Health Aff,20,64-78